Detail page

Knowledge Web

Person

Arnim Gaebler (1986-)

Arzt

Name	Arnim Gaebler
Time	1986- (Date of birth and death)
Place	Hamburg (Geburtsort) Deutschland
Gender	männlich
Academic degree	Dr. med.
Profession	Arzt (characteristic profession)
Variant	Arnim Johannes Gaebler (vollständiger Name)
Related	Klinik für Psychiatrie, Psychotherapie und Psychosomatik
Further information	Promotion an der RWTH Aachen, Medizinische Fakultät, 2016; seit 03/2016 Assistenzarzt in der Klinik für Psychiatrie, Psychotherapie und Psychosomatik des Universitätsklinikums RWTH Aachen
Source	Vorlage
Record type	Person
GND-Identifier	1104721155
Record ID	1104721155
Involved in show all Discovering interactions in polypharmacy: Impact of metamizole on the metabolism of quetiapine Functional connectivity signatures of NMDAR dysfunction in schizophrenia—integrating findings from imaging genetics and pharmaco-fMRI Lower sertraline plasma concentration in patients co‐medicated with clozapine—Implications for pharmacological augmentation strategies in schizophrenia The negative impact of vitamin D on antipsychotic drug exposure may counteract its potential benefits in schizophrenia Subtherapeutic bupropion and hydroxybupropion serum concentrations in a patient with CYP2C191/17 genotype suggesting a rapid metabolizer status Metamizole but not ibuprofen reduces the plasma concentration of sertraline: Implications for the concurrent treatment of pain and depression/anxiety disorders Auditory mismatch impairments are characterized by core neural dysfunctions in schizophrenia

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Arnim Gaebler (1986-)

Discovering interactions in polypharmacy: Impact of metamizole on the metabolism of quetiapine

Functional connectivity signatures of NMDAR dysfunction in schizophrenia—integrating findings from imaging genetics and pharmaco-fMRI

Lower sertraline plasma concentration in patients co‐medicated with clozapine—Implications for pharmacological augmentation strategies in schizophrenia

The negative impact of vitamin D on antipsychotic drug exposure may counteract its potential benefits in schizophrenia

Subtherapeutic bupropion and hydroxybupropion serum concentrations in a patient with CYP2C19*1/*17 genotype suggesting a rapid metabolizer status

Metamizole but not ibuprofen reduces the plasma concentration of sertraline: Implications for the concurrent treatment of pain and depression/anxiety disorders

Auditory mismatch impairments are characterized by core neural dysfunctions in schizophrenia

Subtherapeutic bupropion and hydroxybupropion serum concentrations in a patient with CYP2C191/17 genotype suggesting a rapid metabolizer status